|
TAK-390MR Phase 3 Data Presented At Digestive Disease Week
TAP Pharmaceutical Products Inc. have reported results from three pivotal Phase 3 studies evaluating investigational new drug TAK-390MR, the first proton pump inhibitor (PPI) with ...
www.medicalnewstoday.com
Takeda's investigational PPI TAK-390MR demonstrated higher healing ...
Combined results from two Phase 3 studies presented at the American College of Gastroenterology Annual Scientific Meeting in Orlando, Fla., demonstrated that TAK-390MR resulted in ...
www.eurekalert.org
Newswise Medical News | TAK-390MR Demonstrated Higher Healing Rates ...
TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased
www.newswise.com
TAK-390MR Demonstrated Higher Healing Rates Compared To Lansoprazole ...
Combined results from two Phase 3 studies presented at the American College of Gastroenterology Annual Scientific Meeting (ACG) in Orlando, Fla., demonstrated that TAK-390MR ...
www.medicalnewstoday.com
Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing ...
Biden decries 'unbecoming personal attacks' Palin talks economic worries in Appalachian ... All: u.s. world: politics: business: sports: entertainment: sci/tech: health: odd: video ...
www.breitbart.com
TAK-390MR Phase 3 data presented at Digestive Disease Week
TAP Pharmaceutical Products Inc. today reported results from three pivotal Phase 3 studies evaluating investigational new drug TAK-390MR, the first proton pump inhibitor with an ...
www.eurekalert.org
Newswise Medical News | Phase 3 TAK-390MR Data Demonstrates Higher ...
Phase 3 TAK-390MR Data Demonstrates Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
www.newswise.com
Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing ...
Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis ...
www.miamiherald.com
Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing ...
Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis ...
www.smartbrief.com
Takeda Pharmaceuticals North America, Inc.'s Investigational PPI TAK ...
Takeda Pharmaceuticals North America, Inc. 's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade ...
www.biospace.com
|
